TY  - JOUR
T1  - Assessment of thyroid gland function by evaluating of TSH, FT3 and FT4 hormones in untreated cancer patients
A1  - Mazen Almehmadi
A1  - Khalid Alzahrani
A1  - Magdi M.Salih
A1  - Abdulaziz Alsharif
A1  - Naif Alsiwiehri
A1  - Alaa Shafie
A1  - Abdulraheem A. Almalki
A1  - Haytham Dahlawi
A1  - Ayman Al-hazmi
A1  - Ashwaq Al-khalidi
A1  - Njood Al-ghoraibi
A1  - Wedad Al-osaimi
A1  - Ashwaq M Altahli
A1  - Mustafa Halawi
A1  - Abdulrhman M. Almehmadi
JF  - Journal of Advanced Pharmacy Education and Research
JO  - J Adv Pharm Educ Res
SN  - 2249-3379
Y1  - 2020
VL  - 10
IS  - 4
SP  - 37
EP  - 42
N2  - Thyroid-function-test is a routine laboratory exam performed in many patients; the test usually includes TSH, free-T3 (FT3), and free-T4 (FT4). Levels of these hormones can provide essential reading to evaluate thyroid gland functions. 92 patients were recruited into this study, mostly females diagnosed either with female-genital tract cancer or breast cancer. Levels of TSH, FT3, and FT4 were evaluated by ROCHE COBAS ® platform e501; TSH normal levels are 0.51 to 4.1 μIU/ml, FT3 between 3.6 to 6.9 pmol\L, and FT4 between 12.3 to 20.2 pmol\L. The results of this study indicate different levels of TSH, FT3, and FT4 from most cancer patients, and hypothyroidism in gastrointestinal tract cancer patients. Also, premenopausal females with cancer have shown signs of hypothyroidism. To conclude, normal levels of TSH, FT3, and FT4 were detected in most of this study patients, hypothyroidism was detected in the gastrointestinal tract and part of pre and post-menopause female cancer patients.
UR  - https://japer.in/article/assessment-of-thyroid-gland-function-by-evaluating-of-tsh-ft3-and-ft4-hormones-in-untreated-cancer-patients
ER  -